Apžvalga
Akcijų kainos pasikeitimas
24 val.
Dabar
Min
10.11
Max
10.31
Rekomendacijos | Parduoti |
|---|---|
12 mėnesių prognozė | -22.1% downside |
Kitas uždarbis | 2026-11-05 |
|---|
Ginkgo Bioworks Holdings Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Susijusios naujienos
2026-10-16 23:51; UTC
Ginkgo Bioworks Holdings Inc shares are trading lower in after-market hours, reflecting broader market declines amid inflation concerns and rising borrowing costs.
Skaityti
2026-10-15 20:08; UTC
Sharply higher after $200M offering, clinical updates; sympathy with Ginkgo.
Skaityti
2026-10-14 23:21; UTC
Ginkgo Bioworks Holdings Inc is trading lower in after-market hours, reflecting broader market declines driven by poor tech earnings and rising crude oil prices.
Skaityti
2026-10-13 22:06; UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market trading, having retraced from an earlier peak and reaching a low nearly 1.9% below Tuesday's close.
Skaityti
2026-10-12 23:16; UTC
Ginkgo Bioworks Holdings Inc gained slightly in after-market trading, maintaining a position roughly flat since Monday's close.
Skaityti
2026-10-10 00:01; UTC
Ginkgo Bioworks Holdings Inc is trading modestly higher in after-market hours, supported by a strong broader market backdrop and positioning above its 20-day moving average.
Skaityti
2026-10-09 20:02; UTC
Ginkgo Bioworks joins the National Science Foundation’s X-Labs program, committing $1.5 billion in in-kind support for independent research teams.
Skaityti
2026-10-08 23:42; UTC
Ginkgo Bioworks to provide in-kind access to its Boston lab for the National Science Foundation’s $1.5 billion X-Labs program supporting independent research teams.
Skaityti
2026-10-07 23:51; UTC
Ginkgo Bioworks Holdings Inc is trading lower in after-market hours, marking its third consecutive session of declines following a significant dip earlier in the day.
Skaityti
2026-10-06 20:02; UTC
Ginkgo Bioworks Holdings Inc shares fell sharply after an earlier session high, continuing a significant decline since Monday's close amid mixed social media sentiment.
Skaityti
2026-10-05 20:02; UTC
Ginkgo Bioworks Holdings Inc gains amid positive online commentary about its growth potential and connection to GPT-5, despite trading lower compared to earlier sessions.
Skaityti
2026-10-02 20:07; UTC
Ginkgo Bioworks Holdings Inc shares fell sharply, continuing a decline from Thursday's close despite remaining above its 20-day moving average.
Skaityti
2026-10-01 23:06; UTC
Ginkgo Bioworks Holdings Inc is trading modestly lower in after-market hours, retracing from a brief peak earlier, despite strong performance over the past month.
Skaityti
2026-09-30 20:02; UTC
Ginkgo Bioworks is trading higher after securing a $17.5 million contract from ARPA-H and expanding its Nebula lab, now the world's largest autonomous lab.
Skaityti
2026-09-29 23:11; UTC
Ginkgo Bioworks Holdings Inc. sees increased social media attention and gains in after-market trading, maintaining a strong upward trend above its 20-day moving average.
Skaityti
2026-09-28 23:06; UTC
Ginkgo Bioworks Holdings Inc traded roughly flat during after-market hours, remaining well above its 20-day moving average amid broader market gains over the past month.
Skaityti
2026-09-25 20:02; UTC
Ginkgo Bioworks Holdings Inc. shares are higher as CEO highlights maturing investments in autonomous lab robotics and advancements in AI driving business momentum.
Skaityti
2026-09-24 23:06; UTC
Ginkgo Bioworks is integrating GPT-5 into its cloud lab for protein synthesis, but shares are trading lower in after-market hours amid broader market declines.
Skaityti
2026-09-23 23:05; UTC
Ginkgo Bioworks Holdings Inc is higher in after-market trading, gaining ground since Wednesday's close, and is over 19% above its 20-day moving average.
Skaityti
2026-09-22 20:02; UTC
Ginkgo Bioworks Holdings Inc is sharply higher on Tuesday, marking a notable break from recent upward momentum observed in prior sessions.
Skaityti
2026-09-21 20:06; UTC
Ginkgo Bioworks Holdings Inc is advancing as the broader market remains higher, maintaining an upward trend and trading above its 20-day moving average.
Skaityti
2026-09-18 20:06; UTC
Ginkgo Bioworks Holdings Inc is seeing modest gains, maintaining a position significantly above its 20-day moving average despite fluctuations earlier in the day.
Skaityti
2026-09-17 20:02; UTC
Ginkgo Bioworks shares rise sharply amid notable call options trading, supported by gains in the ARK Genomic Revolution ETF, despite an earlier pullback.
Skaityti
2026-09-16 19:26; UTC
Ginkgo Bioworks announced a partnership with Eli Lilly's TuneLab to enhance drug development efficiency, as shares fell slightly since Tuesday's close.
Skaityti
2026-09-15 20:07; UTC
Ginkgo Bioworks shares are lower, reflecting broader market declines amid negative economic indicators and rising oil prices. Earlier, shares briefly rebounded before pulling back.
Skaityti
2026-09-14 23:06; UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market hours. The broader market faces pressure from rising crude oil prices amid supply concerns.
Skaityti
2026-09-02 19:56; UTC
Ginkgo Bioworks is gaining traction amid social media discussions on Pfizer and Google announcements, despite a generally negative market environment.
Skaityti
2026-09-01 23:06; UTC
Ginkgo Bioworks shares are higher in after-market trading, reaching a peak above the previous day's close. The stock remains below its 20-day moving average.
Skaityti
2026-08-31 22:16; UTC
Ginkgo Bioworks Holdings Inc is trading higher in after-market hours, influenced by broader market reactions to comments on inflation and interest rate expectations.
Skaityti
2026-08-28 22:02; UTC
Ginkgo Bioworks Holdings Inc shares are higher in after-market trading, continuing a recent trend of daily gains despite no specific news to explain the move.
Skaityti
Akcijų palyginimas
Kainos pokytis
Ginkgo Bioworks Holdings Inc Prognozė
Kainos tikslas
By TipRanks
12 mėnesių prognozė
Vidutinis 8 USD -22.1%
Aukščiausias 11 USD
Žemiausias 5 USD
Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Ginkgo Bioworks Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.
Bendras įvertinimas
By TipRanks
Parduoti
3 ratings
0
Pirkti
1
Laikyti
2
Parduoti
Remiantis 3 analitikų, pateikusių Ginkgo Bioworks Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.
Finansinės naujienos
$